Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLA-DRA anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement HLA-DRA dans FACS et IF. Il présente une réactivité envers Humain et Singe.
N° du produit ABIN6939635

Aperçu rapide pour HLA-DRA anticorps (ABIN6939635)

Antigène

Voir toutes HLA-DRA Anticorps
HLA-DRA (HLA Class II DR alpha (HLA-DRA))

Reactivité

  • 97
  • 16
  • 10
  • 9
  • 9
  • 9
  • 4
  • 3
  • 3
  • 1
Humain, Singe

Hôte

  • 62
  • 49
  • 4
  • 1
  • 1
Souris

Clonalité

  • 67
  • 50
Monoclonal

Conjugué

  • 59
  • 12
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Cet anticorp HLA-DRA est non-conjugé

Application

  • 55
  • 52
  • 40
  • 34
  • 19
  • 16
  • 13
  • 10
  • 9
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunofluorescence (IF)

Clone

IPO-10
  • Specificité

    MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50 % of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70 % of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected. '

    Purification

    Purified by Protein A/G

    Immunogène

    Spleen cells of a patient with hairy cell leukemia (Daudi cells)

    Isotype

    IgG3 kappa
  • Indications d'application

    Positive Control: Ramos, Daudi or HuT78 cells. Tonsil or lymph node.

    Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    HLA-DRA (HLA Class II DR alpha (HLA-DRA))

    Autre désignation

    HLA-DRA

    Poids moléculaire

    ~36kDa

    ID gène

    3122

    UniProt

    P01903

    Pathways

    TCR Signaling, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Vous êtes ici:
Chat with us!